Torrent Pharma

50
Hold
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE685A01028
  • NSEID: TORNTPHARM
  • BSEID: 500420
INR
4,439.55
-8.85 (-0.2%)
BSENSE

Jun 18

BSE+NSE Vol: 3.22 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
13,979.00
11,516.00
10,727.00
9,620.00
8,508.00
8,004.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
13,979.00
11,516.00
10,727.00
9,620.00
8,508.00
8,004.00
Expenditure (Ex Depriciation)
Stock Adjustments
11.00
-274.00
-155.00
166.00
73.00
-279.00
Raw Materials Consumed
3,376.00
3,050.00
2,841.00
2,569.00
2,368.00
2,425.00
Power & Fuel Cost
160.00
137.00
145.00
155.00
144.00
122.00
Employee Cost
2,670.00
2,203.00
1,984.00
1,677.00
1,526.00
1,439.00
Operating Expenses
272.00
215.00
197.00
176.00
183.00
163.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
1,490.00
1,260.00
1,129.00
1,026.00
884.00
742.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
767.00
681.00
672.00
530.00
501.00
496.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
9,421.00
7,795.00
7,360.00
6,778.00
6,076.00
5,524.00
Operating Profit (PBDIT) excl Other Income
4,558.00
3,720.00
3,367.00
2,842.00
2,431.00
2,480.00
Other Income
-93.00
23.00
57.00
45.00
196.00
56.00
Operating Profit (PBDIT)
4,464.00
3,744.00
3,425.00
2,887.00
2,627.00
2,536.00
Interest
385.00
252.00
353.00
333.00
255.00
352.00
Profit before Depriciation and Tax
4,079.00
3,491.00
3,072.00
2,553.00
2,372.00
2,184.00
Depreciation
1,118.00
794.00
808.00
706.00
662.00
657.00
Profit Before Taxation & Exceptional Items
2,960.00
2,697.00
2,263.00
1,847.00
1,710.00
1,526.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
2,872.00
2,672.00
2,352.00
1,847.00
1,225.00
1,526.00
Provision for Tax
734.00
761.00
695.00
601.00
448.00
274.00
Profit After Tax
2,138.00
1,911.00
1,656.00
1,245.00
777.00
1,251.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
4,746.00
3,942.00
3,303.00
2,916.00
2,806.00
1,893.00
Profit Available for appropriations
6,909.00
5,853.00
4,959.00
4,161.00
3,583.00
3,144.00
Appropriations
6,909.00
5,853.00
4,959.00
4,161.00
3,583.00
3,144.00
Equity Dividend (%)
760.00%
640.00%
560.00%
440.00%
960.00%
700.00%
Earnings Per Share
63.92
56.47
48.94
36.79
22.96
73.98
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 21.39% vs 7.35% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 22.51% vs 10.49% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 52.62% vs -28.64% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 11.87% vs 15.39% in Mar 2025

Compare Profit and Loss Results of Torrent Pharma
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
13,979.00
9,360.00
4,619.00
49.35%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
13,979.00
9,360.00
4,619.00
49.35%
Expenditure (Ex Depriciation)
Stock Adjustments
11.00
-96.00
107.00
111.46%
Raw Materials Consumed
3,376.00
3,821.00
-445.00
-11.65%
Power & Fuel Cost
160.00
465.00
-305.00
-65.59%
Employee Cost
2,670.00
1,243.00
1,427.00
114.80%
Operating Expenses
272.00
387.00
-115.00
-29.72%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1,490.00
136.00
1,354.00
995.59%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
767.00
157.00
610.00
388.54%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
9,421.00
6,391.00
3,030.00
47.41%
Operating Profit (PBDIT) excl Other Income
4,558.00
2,969.00
1,589.00
53.52%
Other Income
-93.00
352.00
-445.00
-126.42%
Operating Profit (PBDIT)
4,464.00
3,321.00
1,143.00
34.42%
Interest
385.00
3.00
382.00
12,733.33%
Profit before Depriciation and Tax
4,079.00
3,318.00
761.00
22.94%
Depreciation
1,118.00
402.00
716.00
178.11%
Profit Before Taxation & Exceptional Items
2,960.00
2,916.00
44.00
1.51%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
2,872.00
2,916.00
-44.00
-1.51%
Provision for Tax
734.00
725.00
9.00
1.24%
Profit After Tax
2,138.00
2,191.00
-53.00
-2.42%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
4,746.00
11,786.00
-7,040.00
-59.73%
Profit Available for appropriations
6,909.00
13,977.00
-7,068.00
-50.57%
Appropriations
6,909.00
13,977.00
-7,068.00
-50.57%
Equity Dividend (%)
760%
1500%
-740.00
Earnings Per Share
63.92
82.53
-18.61
-22.55%
Profit And Loss - Net Sales
Net Sales 13,979.73 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 21.39% vs 7.35% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4,558.46 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 22.51% vs 10.49% in Mar 2025

Profit And Loss - Interest
Interest 385.07 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 52.62% vs -28.64% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 2,138.18 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 11.87% vs 15.39% in Mar 2025